DE3223499T1 - Quaternary piperidinium halides - Google Patents
Quaternary piperidinium halidesInfo
- Publication number
- DE3223499T1 DE3223499T1 DE823223499T DE3223499T DE3223499T1 DE 3223499 T1 DE3223499 T1 DE 3223499T1 DE 823223499 T DE823223499 T DE 823223499T DE 3223499 T DE3223499 T DE 3223499T DE 3223499 T1 DE3223499 T1 DE 3223499T1
- Authority
- DE
- Germany
- Prior art keywords
- compound
- formula
- methoxybenzoyl
- amino
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- -1 PIPERIDINIUM HALIDES Chemical class 0.000 title description 5
- 150000001875 compounds Chemical class 0.000 claims description 14
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 4
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims description 3
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 3
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 3
- 125000000217 alkyl group Chemical group 0.000 claims description 3
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 3
- 229910052794 bromium Inorganic materials 0.000 claims description 3
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 claims description 3
- 229910052801 chlorine Inorganic materials 0.000 claims description 3
- 239000000460 chlorine Substances 0.000 claims description 3
- 229910052736 halogen Inorganic materials 0.000 claims description 3
- 150000002367 halogens Chemical group 0.000 claims description 3
- 229910052740 iodine Inorganic materials 0.000 claims description 3
- 239000011630 iodine Substances 0.000 claims description 3
- 238000000034 method Methods 0.000 claims description 3
- 125000001999 4-Methoxybenzoyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1OC([H])([H])[H])C(*)=O 0.000 claims description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 2
- 239000003960 organic solvent Substances 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 2
- 238000010992 reflux Methods 0.000 claims description 2
- 239000007795 chemical reaction product Substances 0.000 claims 1
- 125000005843 halogen group Chemical group 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- VOGFBLDDNZRUDZ-UHFFFAOYSA-N n-[2-[2-(1,1-dimethylpiperidin-1-ium-2-yl)ethyl]phenyl]-4-methoxybenzamide;iodide Chemical compound [I-].C1=CC(OC)=CC=C1C(=O)NC1=CC=CC=C1CCC1[N+](C)(C)CCCC1 VOGFBLDDNZRUDZ-UHFFFAOYSA-N 0.000 claims 1
- ROFVJSWBDQUQGW-UHFFFAOYSA-N piperidin-1-ium;bromide Chemical compound Br.C1CCNCC1 ROFVJSWBDQUQGW-UHFFFAOYSA-N 0.000 claims 1
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 15
- PJWPNDMDCLXCOM-UHFFFAOYSA-N encainide Chemical compound C1=CC(OC)=CC=C1C(=O)NC1=CC=CC=C1CCC1N(C)CCCC1 PJWPNDMDCLXCOM-UHFFFAOYSA-N 0.000 description 10
- 229960001142 encainide Drugs 0.000 description 10
- 239000002904 solvent Substances 0.000 description 7
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- 238000005481 NMR spectroscopy Methods 0.000 description 6
- 241000699670 Mus sp. Species 0.000 description 5
- 230000003288 anthiarrhythmic effect Effects 0.000 description 5
- 230000001988 toxicity Effects 0.000 description 5
- 231100000419 toxicity Toxicity 0.000 description 5
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical group C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- 206010003119 arrhythmia Diseases 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 125000004433 nitrogen atom Chemical group N* 0.000 description 2
- IOLCXVTUBQKXJR-UHFFFAOYSA-M potassium bromide Chemical compound [K+].[Br-] IOLCXVTUBQKXJR-UHFFFAOYSA-M 0.000 description 2
- LOUPRKONTZGTKE-LHHVKLHASA-N quinidine Chemical compound C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@H]2[C@@H](O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-LHHVKLHASA-N 0.000 description 2
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 1
- 241000906446 Theraps Species 0.000 description 1
- 206010047281 Ventricular arrhythmia Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000003416 antiarrhythmic agent Substances 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- AGEZXYOZHKGVCM-UHFFFAOYSA-N benzyl bromide Chemical compound BrCC1=CC=CC=C1 AGEZXYOZHKGVCM-UHFFFAOYSA-N 0.000 description 1
- LOUPRKONTZGTKE-UHFFFAOYSA-N cinchonine Natural products C1C(C(C2)C=C)CCN2C1C(O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-UHFFFAOYSA-N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 1
- 231100000636 lethal dose Toxicity 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- XICNVRJHHCHOGI-UHFFFAOYSA-N n-[2-[2-(1-benzyl-1-methylpiperidin-1-ium-2-yl)ethyl]phenyl]-4-methoxybenzamide;bromide;hydrate Chemical compound O.[Br-].C1=CC(OC)=CC=C1C(=O)NC1=CC=CC=C1CCC1[N+](CC=2C=CC=CC=2)(C)CCCC1 XICNVRJHHCHOGI-UHFFFAOYSA-N 0.000 description 1
- 230000000926 neurological effect Effects 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 125000003386 piperidinyl group Chemical group 0.000 description 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 1
- 229960001404 quinidine Drugs 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- CZDYPVPMEAXLPK-UHFFFAOYSA-N tetramethylsilane Chemical compound C[Si](C)(C)C CZDYPVPMEAXLPK-UHFFFAOYSA-N 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Heart & Thoracic Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/229,244 US4321386A (en) | 1981-01-28 | 1981-01-28 | Quaternary piperidinium halides |
| PCT/US1982/000108 WO1982002551A1 (en) | 1981-01-28 | 1982-01-27 | Quaternary piperidinium halides |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE3223499T1 true DE3223499T1 (de) | 1983-01-13 |
| DE3223499C2 DE3223499C2 (enExample) | 1989-11-23 |
Family
ID=22860396
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE823223499T Granted DE3223499T1 (de) | 1981-01-28 | 1982-01-27 | Quaternary piperidinium halides |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US4321386A (enExample) |
| JP (1) | JPH0348904B2 (enExample) |
| AR (1) | AR230266A1 (enExample) |
| AT (1) | AT378183B (enExample) |
| AU (1) | AU551523B2 (enExample) |
| BE (1) | BE891938A (enExample) |
| CA (1) | CA1184917A (enExample) |
| CH (1) | CH651021A5 (enExample) |
| DE (1) | DE3223499T1 (enExample) |
| DK (1) | DK156649C (enExample) |
| FI (1) | FI65239C (enExample) |
| GB (1) | GB2100736B (enExample) |
| GR (1) | GR74720B (enExample) |
| IE (1) | IE52420B1 (enExample) |
| IT (1) | IT1147809B (enExample) |
| NL (1) | NL8220049A (enExample) |
| SE (1) | SE435057B (enExample) |
| WO (1) | WO1982002551A1 (enExample) |
| YU (1) | YU43063B (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI1007624A2 (pt) * | 2009-04-09 | 2016-07-26 | Cognition Therapeutics Inc | composto, método para preparar uma composição, composto ou sal farmaceuticamente aceitável deste e uso de um composto ou um sal farmaceuticamente aceitável deste |
| SG10201506978UA (en) | 2009-07-31 | 2015-10-29 | Cognition Therapeutics Inc | Inhibitors Of Cognitive Decline |
| WO2012106426A1 (en) | 2011-02-02 | 2012-08-09 | Cognition Therapeutics, Inc. | Isolated compounds from turmeric oil and methods of use |
| EP3099296B1 (en) | 2014-01-31 | 2019-01-30 | Cognition Therapeutics, Inc. | Isoindoline derivative, compositions and methods for treating neurodegenerative disease |
| US11214540B2 (en) | 2017-05-15 | 2022-01-04 | Cognition Therapeutics, Inc. | Compositions for treating neurodegenerative diseases |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3037910A (en) * | 1958-04-18 | 1962-06-05 | Burroughs Wellcome Co | Process for treatment of hypertension |
| US3931195A (en) * | 1971-03-03 | 1976-01-06 | Mead Johnson & Company | Substituted piperidines |
| US3917679A (en) * | 1974-04-12 | 1975-11-04 | Lilly Co Eli | Quaternary ammonium salts of N-dialkylaminoalkyl-N-(2-indanyl)anilines |
-
1981
- 1981-01-28 US US06/229,244 patent/US4321386A/en not_active Expired - Lifetime
-
1982
- 1982-01-27 CH CH5828/82A patent/CH651021A5/de not_active IP Right Cessation
- 1982-01-27 WO PCT/US1982/000108 patent/WO1982002551A1/en not_active Ceased
- 1982-01-27 JP JP57500784A patent/JPH0348904B2/ja not_active Expired - Lifetime
- 1982-01-27 AT AT0900782A patent/AT378183B/de active
- 1982-01-27 DE DE823223499T patent/DE3223499T1/de active Granted
- 1982-01-27 AU AU81485/82A patent/AU551523B2/en not_active Ceased
- 1982-01-27 GB GB08220076A patent/GB2100736B/en not_active Expired
- 1982-01-28 BE BE0/207171A patent/BE891938A/fr not_active IP Right Cessation
- 1982-01-28 YU YU197/82A patent/YU43063B/xx unknown
- 1982-01-28 IE IE191/82A patent/IE52420B1/en unknown
- 1982-01-28 NL NL8220049A patent/NL8220049A/nl unknown
- 1982-01-28 CA CA000395068A patent/CA1184917A/en not_active Expired
- 1982-01-28 AR AR288281A patent/AR230266A1/es active
- 1982-01-28 GR GR67146A patent/GR74720B/el unknown
- 1982-01-28 IT IT47667/82A patent/IT1147809B/it active
- 1982-07-08 FI FI822443A patent/FI65239C/fi not_active IP Right Cessation
- 1982-09-27 DK DK429382A patent/DK156649C/da not_active IP Right Cessation
- 1982-09-28 SE SE8205535A patent/SE435057B/sv not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| AR230266A1 (es) | 1984-03-01 |
| AT378183B (de) | 1985-06-25 |
| IT1147809B (it) | 1986-11-26 |
| SE435057B (sv) | 1984-09-03 |
| US4321386A (en) | 1982-03-23 |
| AU8148582A (en) | 1982-08-16 |
| IT8247667A0 (it) | 1982-01-28 |
| AU551523B2 (en) | 1986-05-01 |
| GB2100736A (en) | 1983-01-06 |
| DK156649C (da) | 1990-02-05 |
| GR74720B (enExample) | 1984-07-10 |
| JPS57502216A (enExample) | 1982-12-16 |
| ATA900782A (de) | 1984-11-15 |
| DE3223499C2 (enExample) | 1989-11-23 |
| SE8205535L (sv) | 1982-09-28 |
| FI822443A0 (fi) | 1982-07-08 |
| GB2100736B (en) | 1985-01-30 |
| NL8220049A (nl) | 1982-11-01 |
| FI65239B (fi) | 1983-12-30 |
| YU19782A (en) | 1985-04-30 |
| DK156649B (da) | 1989-09-18 |
| YU43063B (en) | 1989-02-28 |
| FI65239C (fi) | 1984-04-10 |
| IE52420B1 (en) | 1987-10-28 |
| FI822443L (fi) | 1982-07-08 |
| BE891938A (fr) | 1982-07-28 |
| CA1184917A (en) | 1985-04-02 |
| IE820191L (en) | 1982-07-28 |
| SE8205535D0 (sv) | 1982-09-28 |
| DK429382A (da) | 1982-09-27 |
| CH651021A5 (de) | 1985-08-30 |
| JPH0348904B2 (enExample) | 1991-07-25 |
| WO1982002551A1 (en) | 1982-08-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0026848B1 (de) | Tetralinderivate, ihre Herstellung und Heilmittel, welche diese Verbindungen enthalten | |
| DE2024001B2 (de) | Tetrahydrofurfuryloxyphenoxypropanolamine und deren pharmakologisch verträgliche Säureadditionssalze und Verfahren zu deren Herstellung sowie diese Verbindungen enthaltende Arzneimittel | |
| DD202152A5 (de) | Verfahren zur herstellung von phenylpiperazinderivaten | |
| DE2657978C3 (de) | Linksdrehende Enantiomere und Racemate von Trifluormethylthio(und -sulfonyl)cyproheptadinderivaten, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel | |
| DE2407115A1 (de) | Neue 1,4-dihydropyridinderivate | |
| EP0503411B1 (de) | Substituierte N-Phenylpiperidine und Arzneimittel daraus | |
| DD147537A5 (de) | Verfahren zur herstellung von 1,2,4,5-tetra-alkyl-4-aryl-piperidinen | |
| DE3223499C2 (enExample) | ||
| DE1925956C3 (de) | 4- [3-(subst- Amino)-2-hydroxypropoxy] -1,2,5thiadiazolverbindungen und ein diese Verbindungen enthaltendes pharmazeutisches Mittel | |
| DE4131584A1 (de) | Imidazolylmethyl-pyridine, ihre herstellung und anwendung als pharmazeutika | |
| DE3900028A1 (de) | Gegebenenfalls am phenylrest halogen- und/oder alkyl- und/oder alkoxy- oder methylendioxysubstituierte, 5,5-di-(methyl)-3-(phenylvinyl)-1-(substituiert amino-alkoxy-imino)-cyclohex-2-enderivate, verfahren zu ihrer herstellung sowie diese enthaltende arzneimittel | |
| DE2724478C2 (de) | 5,11-Dihydro-6H-pyrido[2,3-b][1,4]benzodiazepin-6-on-derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel | |
| DE1915230A1 (de) | Hydroxyphenylalkylaminderivate und Verfahren zu deren Herstellung | |
| DE2425767A1 (de) | 3-alkyl-9-aminoalkyl-1,2,3,4-tetrahydrocarbazole und ihre verwendung in arzneimitteln | |
| CH623562A5 (enExample) | ||
| DE3876546T2 (de) | Ethanon-oxime. | |
| CH615665A5 (en) | Process for the preparation of the Z-isomer of 3-(4-bromophenyl)-N-methyl-3-(3-pyridyl)allylamine | |
| DE2425306C2 (de) | Imidazolido [1,5-c] thiazolidin-3-spiro-4'- [1'-(4-p-fluorphenyl-4-oxobutyl)-piperidin] -derivate, ihre Salze, Verfahren zu ihrer Herstellung und ihre Verwendung | |
| DE2903917C2 (enExample) | ||
| DE2311067C2 (de) | Diphenylmethoxyäthylamine, Verfahren zu deren Herstellung und Verwendung von Diphenylmethoxyäthylaminen bei der Bekämpfung der Parkinson-Krankheit | |
| DE2035535A1 (de) | Eckige Klammer auf 3 Alkoxy 2 (diaryl) methyl eckige Klammer zu propylamine, ihre Herstellung und Verwendung | |
| DE3027338C2 (de) | Isochinolinderivate, ihre Salze, Verfahren zu ihrer Herstellung und therapeutische Zubereitung | |
| DE2062055A1 (de) | Propanolamin Derivate | |
| DE2259012C3 (de) | 8beta-Pvrimidyl-(2)-aminomethyl-10 a-ergolinderivate und Verfahren zu ihrer Herstellung | |
| DE2638849A1 (de) | Aminosaeureester, verfahren zu ihrer herstellung und sie enthaltende arzneimittel |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8110 | Request for examination paragraph 44 | ||
| D2 | Grant after examination | ||
| 8364 | No opposition during term of opposition | ||
| 8327 | Change in the person/name/address of the patent owner |
Owner name: BRISTOL-MYERS SQUIBB CO. (N.D.GES.D.STAATES DELAWA |
|
| 8328 | Change in the person/name/address of the agent |
Free format text: KINZEBACH, W., DIPL.-CHEM. DR.PHIL. RIEDL, P., DIPL.-CHEM.DR.RER.NAT., PAT.-ANWAELTE, 8000 MUENCHEN |
|
| 8339 | Ceased/non-payment of the annual fee |